ADC Linkers

抗体药物偶联物(ADC)由所需的单克隆抗体、活性细胞毒性药物和适当的连接子组成。抗体和细胞毒性药物之间的适当连接子提供了特定的桥梁,从而帮助抗体选择性地将细胞毒性药物递送至肿瘤细胞并准确地在肿瘤部位释放细胞毒性药物。除了偶联作用外,连接子在ADC的制备和储存阶段以及体循环期间维持ADC的稳定性。

目前正在进行临床评估的ADC含有的连接子主要分为两类:可裂解和不可裂解。可裂解的连接子依赖于细胞内部的过程来释放毒素,例如在细胞质中还原、在溶酶体中暴露于酸性条件或被细胞内的特定蛋白酶裂解。不可裂解的接头需要 ADC 的抗体部分发生蛋白水解降解才能释放细胞毒性分子,而细胞毒性分子会保留接头和与抗体连接的氨基酸。

接头的选择取决于靶标,基于对抗体-靶抗原复合物内化和降解的了解,以及偶联物的临床前体外和体内活性比较。此外,接头的选择还受所用细胞毒素的影响,因为每种分子都有不同的化学约束,并且药物结构通常适合特定的接头。

Antibody-drug conjugates (ADCs) consist of a desirable monoclonal antibody, an active cytotoxic drug and an appropriate linker. An appropriate linker between the antibody and the cytotoxic drug provides a specific bridge, and thus helps the antibody to selectively deliver the cytotoxic drug to tumor cells and accurately releases the cytotoxic drug at tumor sites. In addition to conjugation, the linkers maintain ADCs’ stability during the preparation and storage stages of the ADCs and during the systemic circulation period.

The ADCs currently undergoing clinical evaluation contain linkers are mostly classified into two categories: cleavable and noncleavable. Cleavable linkers rely on processes inside the cell to liberate the toxin, such as reduction in the cytoplasm, exposure to acidic conditions in the lysosome, or cleavage by specific proteases within the cell. Noncleavable linkers require proteolytic degradation of the antibody portion of the ADC for release of the cytotoxic molecule, which will retain the linker and the amino acid by which it was attached to the antibody.

The selection of linker is target dependent, based on the knowledge of the internalization and degradation of the antibody-target antigen complex, and a preclinical in vitro and in vivo activity comparison of conjugates. Moreover, the choice of a linker is also influenced by which cytotoxin is used, as each molecule has different chemical constraints, and frequently the drug structure lends itself to a specific linker.

By Effects: Chemical (3)
共 3种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
Boc-Gly-Gly-NHS ester

Boc-Gly-Gly-NHS ester 可用于选择性地将小分子附着到蛋白质上的特定氨基酸残基上,从而形成可用于药物发现和诊断检测中各种应用的结合物。

29248-48-4
Chemical
97.0%
Boc-Gly-Gly-NHS ester
DBCO-PEG3-C1-acid

DBCO-PEG3-C1-acid 是一种抗体-药物偶联物 (ADC) 连接体,可作为反应手柄用于菌株促进的叠氮化物-炔烃点击反应。

2249926-65-4
Chemical
DBCO-PEG3-C1-acid
Zuvotolimod

Zuvotolimod 是一种用于骨髓细胞激动剂-抗体偶联物的化合物 linker,可用于癌症与肝炎的研究。

2355262-97-2
Chemical
99.46%
Zuvotolimod

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础